These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35438513)

  • 21. Broad defeats Berkeley CRISPR patent.
    Shaffer C
    Nat Biotechnol; 2022 Apr; 40(4):445. PubMed ID: 35288688
    [No Abstract]   [Full Text] [Related]  

  • 22. Cas9 immunity creates challenges for CRISPR gene editing therapies.
    Crudele JM; Chamberlain JS
    Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thinking About CRISPR: The Ethics of Human Genome Editing.
    Barrangou R
    CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
    [No Abstract]   [Full Text] [Related]  

  • 24. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Navigating Viral Space with CRISPR Technologies.
    Barrangou R
    CRISPR J; 2022 Aug; 5(4):487. PubMed ID: 35972366
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiplex gene editing in rice with simplified CRISPR-Cpf1 and CRISPR-Cas9 systems.
    Wang M; Mao Y; Lu Y; Wang Z; Tao X; Zhu JK
    J Integr Plant Biol; 2018 Aug; 60(8):626-631. PubMed ID: 29762900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Better Guidance for CRISPR.
    Barrangou R
    CRISPR J; 2022 Dec; 5(6):741. PubMed ID: 36512349
    [No Abstract]   [Full Text] [Related]  

  • 28. Analyzing CRISPR genome-editing experiments with CRISPResso.
    Pinello L; Canver MC; Hoban MD; Orkin SH; Kohn DB; Bauer DE; Yuan GC
    Nat Biotechnol; 2016 Jul; 34(7):695-7. PubMed ID: 27404874
    [No Abstract]   [Full Text] [Related]  

  • 29. The future of CRISPR technologies in agriculture.
    Gao C
    Nat Rev Mol Cell Biol; 2018 May; 19(5):275-276. PubMed ID: 29382940
    [No Abstract]   [Full Text] [Related]  

  • 30. A highly efficient in vivo plasmid editing tool based on CRISPR-Cas12a and phage λ Red recombineering.
    Geng Y; Yan H; Li P; Ren G; Guo X; Yin P; Zhang L; Qian Z; Zhao Z; Sun YC
    J Genet Genomics; 2019 Sep; 46(9):455-458. PubMed ID: 31607505
    [No Abstract]   [Full Text] [Related]  

  • 31. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 32. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proof-of-principle Intellia trial shows in vivo CRISPR activity.
    Mullard A
    Nat Rev Drug Discov; 2022 Apr; 21(4):249. PubMed ID: 35277676
    [No Abstract]   [Full Text] [Related]  

  • 34. Improving CRISPR tools by elucidating DNA repair.
    Lim JM; Kim HH
    Nat Biotechnol; 2021 Dec; 39(12):1512-1514. PubMed ID: 34873327
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted Base Editing Systems Are Available for Plants.
    Marzec M; Hensel G
    Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amplifying CRISPR: Next-Generation Diagnostics.
    Barrangou R
    CRISPR J; 2023 Apr; 6(2):85. PubMed ID: 37071671
    [No Abstract]   [Full Text] [Related]  

  • 37. What are the current bottlenecks in developing and applying CRISPR technologies?
    Kellogg EH; Gootenberg J; Abudayyeh O; Wong ASL; Dahlman JE; Lapinaite A; Myhrvold C; Liu CC; Hsu PD; Mali P; Qi LS
    Cell Syst; 2022 Aug; 13(8):589-593. PubMed ID: 35981511
    [No Abstract]   [Full Text] [Related]  

  • 38. Review of Altered inheritance: CRISPR and the ethics of human genome editing by Françoise Baylis.
    Sun BZ
    Monash Bioeth Rev; 2020 May; 38(1):91-93. PubMed ID: 32314277
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypercompact CRISPR-Cas12j2 (CasΦ) enables genome editing, gene activation, and epigenome editing in plants.
    Liu S; Sretenovic S; Fan T; Cheng Y; Li G; Qi A; Tang X; Xu Y; Guo W; Zhong Z; He Y; Liang Y; Han Q; Zheng X; Gu X; Qi Y; Zhang Y
    Plant Commun; 2022 Nov; 3(6):100453. PubMed ID: 36127876
    [No Abstract]   [Full Text] [Related]  

  • 40. CRISPR's Path to the Clinic.
    Miccio A
    CRISPR J; 2022 Feb; 5(1):2-3. PubMed ID: 35191749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.